Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

ALBANY, N.Y. — The Albany Med Health System has successfully implanted the world’s first FDA-approved heart failure device designed to treat patients who have had little to no success with other ...

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Please provide your email address to receive an email when new articles are posted on . The American College of Cardiology announced it has expanded the scope of a registry for electrophysiology ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An implantable device that shocks an erratically beating heart back into ...

Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...

WASHINGTON, DC—The vast majority of patients who develop an infection related to a cardiac implanted electronic device (CIED) do not have the hardware extracted in a timely manner, and these patients ...